RDTCF (Rapid Dose Therapeutics) Ending Cash Position : $0.03 Mil (As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Rapid Dose Therapeutics Ending Cash Position?

Rapid Dose Therapeutics's Ending Cash Position for the quarter that ended in Nov. 2024 was $0.03 Mil.

Rapid Dose Therapeutics's quarterly Ending Cash Position declined from May. 2024 ($0.08 Mil) to Aug. 2024 ($0.05 Mil) and declined from Aug. 2024 ($0.05 Mil) to Nov. 2024 ($0.03 Mil).

Rapid Dose Therapeutics's annual Ending Cash Position declined from Feb. 2022 ($0.03 Mil) to Feb. 2023 ($0.02 Mil) but then increased from Feb. 2023 ($0.02 Mil) to Feb. 2024 ($0.12 Mil).

Rapid Dose Therapeutics Ending Cash Position Historical Data

The historical data trend for Rapid Dose Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Dose Therapeutics Ending Cash Position Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Ending Cash Position

Get a 7-Day Free Trial

0.06

0.03

0.02

0.12

Rapid Dose Therapeutics Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
Ending Cash Position	Get a 7-Day Free Trial															0.12	0.12	0.08	0.05	0.03

Rapid Dose Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Rapid Dose Therapeutics's Ending Cash Position for the fiscal year that ended in Feb. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.02	+	0.099
	=	0.12

Rapid Dose Therapeutics's Ending Cash Position for the quarter that ended in Nov. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.051	+	-0.022
	=	0.03

Rapid Dose Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Rapid Dose Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Rapid Dose Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rapid Dose Therapeutics Corp (OTCPK:RDTCF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

DOSE:Canada

Address

1121 Walkers Line, Unit 3, Burlington, ON, CAN, L7N 2G4

Website

https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.